Uterine fibroids, or leiomyoma, are the most common benign tumors in women of reproductive age. In this work, the effect of silencing the mediator complex subunit 12 (Med12) gene in human uterine fibroid cells was evaluated. The role of Med12 in the modulation of Wnt/b-catenin and cell proliferation-associated signaling was evaluated in human uterine fibroid cells. Med12 was silenced in the immortalized human uterine fibroid cell line (HuLM) using a lentivirus-based Med12 gene-specific RNA interference strategy. HuLM cells were infected with lentiviruses carrying Med12-specific short hairpin RNA (shRNA) sequences or a nonfunctional shRNA scrambled control with green fluorescence protein. Stable cells that expressed low levels of Med12 protein were characterized. Wnt/b-catenin signaling, sex steroid receptor signaling, cell cycle-associated, and fibrosisassociated proteins were measured. Med12 knockdown cells showed significantly (P , 0.05) reduced levels of Wnt4 and b-catenin proteins as well as cell proliferation, as compared with scrambled control cells. Med12 knockdown cells also showed reduced levels of cell cycle-associated cyclin D1, Cdk1, and Cdk2 proteins as well as reduced activation of p-extracellular signal-regulated kinase, p-protein kinase B, and transforming growth factor (TGF)-b signaling pathways as compared with scrambled control cells. Moreover, TGF-b-regulated fibrosis-related proteins such as fibronectin, collagen type 1, and plasminogen activator inhibitor-1 were significantly (P , 0.05) reduced in Med12 knockdown cells as compared with scrambled control cells. Together, these results suggest that Med12 plays a key role in the regulation of HuLM cell proliferation through the modulation of Wnt/b-catenin, cell cycle-associated, and fibrosis-associated protein expression. (Endocrinology 158: 592-603, 2017) 
U terine fibroids (UFs), or leiomyomas, are the leading indicator for hysterectomy in reproductive age women (1) (2) (3) . UFs afflict up to 60% of reproductive age women and 80% of all women during their lifetime (4) . Clinically, UFs present with a variety of symptoms that include vaginal bleeding, pelvic pain, infertility and abortion, and preterm birth (5) . The development of human UFs (hUFs) most likely involves several factors, including hormones, various growth factors, and inherent/genetic traits. Gene mutations in the mediator complex subunit 12 (Med12) have recently been shown to play key roles in the pathogenesis of hUFs (6) (7) (8) (9) (10) . Somatic mutations in the Med12 gene have been linked with the induction of gene expression of wingless-type mouse mammary tumor virus integration site family, member 4 (Wnt4) and activation of b-catenin signaling (8) . A recent study of global comparisons of microarray data from UFs versus myometrium in humans and rats showed that the mammalian target of the rapamycin pathway is highly upregulated in both human and rat tumors, and UF growth is dependent upon the activation of mammalian target of the rapamycin signaling (11) . The study by Mittal et al. (12) also demonstrated that conditional expression of a common Med12 variant promotes leiomyoma formation in the uterus and genomic instability in a murine model.
The Mediator is a large complex of 30 subunits and a component of the intricate mechanisms that regulate eukaryotic transcription and thereby control organism development and homeostasis (13, 14) . The Mediator complex is conserved in all eukaryotic organisms and required for the transcription of almost all genes (15, 16) . The Mediator complex interacts directly with a number of transcription factors to facilitate RNA polymerase II recruitment to target genes (17) . Subunits are necessary for all functions of the Mediator, including the interaction with the polymerase II machinery or maintenance of the complex, which are important for cell survival (18, 19) . Med12 has been linked to general functions of the complex and to specific interactions with transcription factors. Med12 is a subunit of the Cdk8 kinase module and has been shown to function as a transducer of Wnt/b-catenin signaling (20) . This module interacts transiently with the other components of the Mediator and functions as a context-dependent positive or negative regulator (21) (22) (23) . A recent study with a Med12 gene knockout demonstrated that it is vital for early mouse embryogenesis and for canonical Wnt and Wnt/planar cell polarity signaling pathways (24) . It has previously been shown that b-catenin physically and functionally targets Med12 subunit to activate transcription, and that Med12 is essential for the transactivation of Wnt/b-catenin signaling (20) . Moreover, Med12 is linked to the modulation of hedgehog signaling (25) and to the regulation of transforming growth factor (TGF)-b receptor signaling (26) . Recently, Prenzel et al. (27) revealed that Med12 is required for the expression of estrogen receptor (ER)-a in human breast cancer cells. Med12 has been shown to be overexpressed in pancreatic cancer, whereas knockdown of Med12 expression inhibits cell cycle progression in pancreatic cancer cells (28) .
Although prior studies have suggested a role for Med12 in association with the canonical Wnt/b-catenin signaling pathway, it has not been clearly established yet as to whether Med12 is directly involved in the modulation of Wnt/b-catenin signaling in hUF cells. The objective of this study is to determine the role of Med12 in the regulation of leiomyoma cell proliferation and to establish its direct link with Wnt/b-catenin and other signaling pathways such as fibrosis and TGF-b3, as these pathways are linked to the pathogenesis of hUFs. In this work, the role of Med12 was established by knockdown of Med12 gene expression in immortalized hUF (HuLM) cells using a lentivirus-based Med12 gene-specific RNA interference (RNAi) strategy. Suppression of Med12 expression affects several signaling pathways, such as Wnt/b-catenin, TGF-b signaling, sex steroid receptor signaling, as well as growth-associated and fibrosisassociated proteins in HuLM cells.
Materials and Methods

Cell lines and cultures
The HuLM cell line was a generous gift of Dr. Darlene Dixon (National Institute of Environmental Health Sciences, Research Triangle Park, NC), as previously described (29) . These cells were grown in smooth muscle cell culture medium with 5% fetal bovine serum at 37°C in a humidified atmosphere of 5% CO 2 , as previously described (30) . Primary human UF cells used in this study were described in our previous paper (31) .
Reagents and antibodies
Antibodies are shown in Table 1 . TGF-b3, anti-fibronectin, and anti-b-actin antibodies were purchased from Sigma Biochemicals (St. Louis, MO). NE-PER™ nuclear and cytoplasmic extraction reagents were purchased from Pierce Biotechnology (Rockford, IL). Monoclonal anti-b-catenin antibody was purchased from BD Biosciences (San Jose, CA). Polyclonal anti-Wnt-4 antibody was purchased from Abcam (Cambridge, MA). Anti-cyclin D1, anti-Cdk1, anti-Cdk2, anti-Cdk4, antiCdk6, anti-ER-a, anti-PR-A, anti-PR-B, anti-plasminogen activator inhibitor (PAI)-1, anti-Smad4, anti-p-extracellular signal-regulated kinase (ERK), anti-ERK, anti-poly(ADPribose) polymerase, and anti-RhoGDI antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-p-protein kinase B (AKT) and anti-AKT antibodies were purchased from Cell Signaling (Danvers, MA). Anti-Smad2 and anti-Smad3 were purchased from Thermo Fisher Scientific Life Sciences, (Waltham, MA). Anti-collagen type 1 antibody was purchased from Fitzgerald (Concord, MA). Anti-fibronectin and anti-b-actin antibodies were purchased from Sigma Biochemicals. Carbocyanine 3-and fluorescein isothiocyanateconjugated secondary antibodies were purchased from Jackson ImmunoResearch Laboratories (West Grove, PA).
Generation of stable Med12 knockdown cells
To examine the role of the Med12 in hUFs, the Med12 gene was silenced by stable expression of Med12 gene-specific short hairpin RNA (shRNA) in HuLM cells. HuLM cells provide an appropriate model to determine the function of Med12 in UF cells. Lentivirus plasmid constructs that contain Med12-specific short shRNA sequences and nonfunctional scrambled control shRNA sequence (Origen) were used. These plasmid constructs express green fluorescence protein and contain a puromycin selection marker gene. These lentivirus constructs were transiently transfected into human embryonic kidney cells (293T using lipofectamin LTX transfection reagent), according to the manufacturer's instructions (Thermo Fisher Scientific Life Sciences). Fifteen hours after transfection, fresh medium was added and cultured for another 48 hours. Supernatant media containing lentiviruses were collected and filtered, and then polybrene solution was added at a concentration of 8 mg/mL. Viruses containing media were used to infect cultured HuLM cells. Fifteen hours after infection, fresh medium was added to continue for another 48 hours. Thereafter, untransfected cells were euthanized press.endocrine.org/journal/endousing 0.5 mg/mL puromycin in preparation of stable polyclonal cell populations, and thereafter individual clones were established. We observed that several clones showed reduced levels of Med12 protein expression [Supplemental Fig. 1(A 
Cell proliferation assay
Cell proliferation assays were performed by direct cell counting, as previously described (32) . Cells (5000/well) from either Med12 knockdown cells or scrambled control cells were seeded onto 12-well tissue culture plates from BD Biosciences (Sumter, SC) and incubated overnight. Cells were then cultured in phenol-free Dulbecco's modified Eagle medium (DMEM)/ F12 medium containing 10% charcoal-stripped fetal bovine serum. Cultures were replenished every other day with fresh conditioned media. Cells were counted at day 0, day 2, day 4, and day 8. Averaged cell numbers from triplicate wells were used for the data graph. Each data point is the mean 6 standard deviation of triplicate wells (n = 3).
Western blot analyses
Med12 knockdown cells and scrambled control cells were cultured in 10-cm tissue culture dishes. Preparation of cell lysates and Western blot analyses were performed, as previously described (31) (32) (33) . The antigen-antibody complex was detected using the Pierce enhanced chemiluminescence Western blotting substrate from ThermoFisher Scientific (Grand Island, NY). Specific protein bands were visualized after exposure to autoradiography films and developed by using automatic x-ray developer. The intensity of each protein band was quantified and normalized against corresponding b-actin, as described in the respective figure legends.
Immunoprecipitation analyses
Immunoprecipitation analyses were performed as described previously (33, 34) . A total of 2.5 3 10 6 cells from both Med12 knockdown and control-shRNA cells was seeded into 10-cm tissue culture dishes and incubated overnight. Cells were preincubated in serum-free DMEM/F12 medium (phenol-free) for 20 hours and then treated with and without TGF-b3 (10 ng/mL) for 4 hours. Cell lysates were prepared from these treated cells, as previously described (34) . Equal amounts of each clear cell lysate (1 mg) were incubated with both anti-Smad2 and antiSmad3 (2 mg each) antibodies for 2.5 hours at 4°C, followed by incubation with 25 mL protein G-Sepharose from Sigma Biochemicals (St. Louis, MO) for an additional hour. Immune complexes were precipitated, washed with incubation buffer, and analyzed by Western blot with monoclonal anti-Smad4 antibody. These cell lysates were also used to verify the protein expression of phospho-Smad2, Smad2, and Smad4.
Nuclear and cytoplasmic fractions
A total of 2 3 10 6 cells from either Med12 knockdown cells or control-shRNA cells was seeded into 10-cm tissue culture dishes and incubated overnight. Cells were serum starved in DMEM/F12 medium (phenol free) overnight and then treated with and without TGF-b3 (10 ng/mL) for 4 hours. Nuclear and cytoplasmic fractions were separated from pelleted cells using NE-PER™ nuclear and cytoplasmic extraction reagents from Pierce Biotechnology (Rockford, IL). A total of 15 mg either cytoplasmic or nuclear fractions was subjected to Western blot analyses, as indicated in figure legends.
Immunofluorescence analyses
Immunofluorescence analyses were performed, as previously described (34) . Med12 knockdown cells and control-shRNA cells were seeded onto glass coverslips and cultured overnight.
After fixation/permeabilization steps, cells were incubated with rabbit polyclonal anti-Smad2 or anti-Smad3 antibodies (10 mg/mL), anti-fibronectin or anti-collagen type 1 (1:50 dilution each), or monoclonal anti-b-catenin (1:100 dilution) for 1 hour at room temperature, followed by incubation for an additional hour with carbocyanine 3-or fluorescein isothiocyanate-conjugated mouse or rabbit secondary antibodies (1:150 dilution). Fluorescent images were taken using an Axiovert 100 M inverted microscope (Carl Zeiss, Oberkochen, Germany). Signal intensities were visually compared between Med12 knockdown cells and scrambled control cells.
Statistical analysis
Student t test was used to assess any significant differences between scrambled control and Med12 knockdown data points. Values were considered statistically significant when P , 0.05 at a 95% confidence. Data were presented as mean 6 standard deviation of three data points (n = 3).
Results
Generation of stable Med12 knockdown clones and scrambled control clones
To examine the function of the Med12 in hUFs, the Med12 gene was knocked down in HuLM cells using a lentivirus-based RNAi strategy. Med12 gene-specific shRNA and nonfunctional scrambled control shRNA plasmid constructs were used to generate lentiviruses in HEK-293T cells. Lentiviruses were used to infect HuLM cells and selected with puromycin, and then higher levels of green fluorescence protein-expressing stable cell populations were acquired [ Fig. 1(A) ]. These polyclonal cell populations were further used to generate individual stable clones. A stable clone that expressed the lowest level of Med12 protein (Med12-shRNA) as well as a parallel scrambled control clone (control-shRNA) was selected for molecular characterization [ Fig. 1(B) ]. These stable cells were used to determine the role of Med12 in hUF cells by several techniques, including protein expression analysis by Western blotting, protein localization by immunofluorescence, and protein-protein interaction by immunoprecipitation assays.
Silencing Med12 reduced Wnt/b-catenin expression in cultured HuLM cells
To test whether Med12 is functionally associated with Wnt/b-catenin signaling, Western blot analyses were performed using lysates from Med12-shRNA cells and scrambled control cells. Med12-shRNA cells showed at least a 53% reduction of endogenous Med12 protein when compared with control-shRNA cells [ Fig. 2 Silencing Med12 reduced cell cycle-associated and tumorigenic proteins in cultured HuLM cells To examine whether Med12 is connected to cell proliferation-associated proteins, Western blot analyses were performed using lysates from Med12-shRNA cells and control-shRNA cells. Med12-shRNA cells expressed reduced levels of cyclin D1, Cdk1, and Cdk2 proteins as compared with control-shRNA cells [ Fig. 3  (A) and 3(B) ]. However, the levels of Cdk4 and Cdk6 were not significantly affected in Med12-shRNA cells when compared with control-shRNA cells. The effect of Med12 knockdown on tumorigenic ERK and AKT signaling was further verified using Western blot analyses. The levels of phospho-ERK and phospho-AKT were significantly lower in Med12-shRNA cells as compared with control-shRNA cells [ Fig. 3 (C) and 3 (D)]. As expected, the levels of total ERK and AKT were unchanged. These results indicate that Med12 regulates cell cycle-associated protein expression and tumorigenic ERK and AKT signaling pathways in HuLM cells.
Silencing Med12 reduced the levels of ER-a, PR-A, and PR-B proteins in cultured HuLM cells
Ovarian steroids, such as estrogen and progesterone, play key signaling roles in the pathogenesis of hUFs (35) (36) (37) . Both ER-a and progesterone receptors (PR-A and PR-B) are upregulated in hUFs and promote fibroid growth (38) (39) (40) (41) . To examine whether Med12 can regulate these sex steroid receptors, Western blot analyses were performed using protein lysates, as described previously. Med12-shRNA cells showed significantly reduced levels of ER-a, PR-A, and PR-B proteins as compared with control-shRNA cells ( Fig. 4 ; P , 0.05), indicating a regulatory role for Med12 on sex steroid receptors in HuLM cells.
Silencing Med12 reduced the levels of fibrosisassociated proteins in cultured HuLM cells
Fibronectin is a key component of the extracellular matrix (ECM) and plays an important role in the process of fibrosis. To test whether Med12 plays a role in the process of fibrosis by modulating the protein expression of fibronectin in HuLM cells, Western blot analyses were performed using lysates from Med12 knockdown cells and scrambled control cells. 
Silencing Med12 reduced TGF-b-induced Smad activation and their complex formation in cultured HuLM cells
To determine whether disruption of Med12 protein expression affects TGF-b3-induced activation of Smad signaling, Western blot analyses were performed using nuclear and cytoplasmic extracts from Med12 knockdown cells and control-shRNA cells. Med12 knockdown cells showed reduced levels of nuclear phospho-Smad2 as compared with control-shRNA cells. TGF-3 treatment induced nuclear phospho-Smad2 within 4 h in controlshRNA cells, whereas this induction was lower in Med12 knockdown cells [ Fig. 6(E) ]. The level of Smad2 was also higher in control-shRNA cells as compared with Med12 press.endocrine.org/journal/endoknockdown cells [ Fig. 6(E) ]. As expected, the level of Smad4 protein was similar in both cell types. Furthermore, treatment with TGF-b3 induced pro-oncogenic cyclin D1 in control-shRNA cells, whereas the levels of cyclin D1 were very low in Med12 knockdown cells, which were not further induced by TGF-b3 [ Fig. 6(E) ]. The expression of poly(ADP-ribose) polymerase was almost exclusively localized in the nuclear fractions, whereas the expression of RhoGDI was almost exclusively localized in the cytosolic fraction [ Fig. 6(E) ], indicating the purity of the separation of both cytosolic and nuclear fractions. These results suggest that Med12 is required for activation of the TGF-b/Smad signaling pathway in HuLM cells. To further examine the heterotrimeric complex formation among Smad2, Smad3, and Smad4, an immunoprecipitation experiment was performed using both Med12-and control-knockdown cells. These stable cells were treated with TGF-b3 (10 ng/mL) for 4 h, and then cell lysates were analyzed by immunoprecipitation assay. This analyses revealed that TGFb3-induced Smad complex formation was significantly 
Discussion
Recent studies have demonstrated that Med12 somatic mutations are frequently associated with hUFs in 85% of fibroid cases, and that Med12 plays critical roles in fibroid pathogenesis (6-10, 42, 43) . It has been demonstrated that approximately 50% of the identified Med12 somatic mutations in fibroid samples correspond to mutations of the 44th codon of exon 2 within the Med12 gene, indicating the specific importance of this amino acid for Med12 function in relation to hUFs, and thus suggesting these somatic mutations could represent gain-of-function alleles (12) . Despite the high prevalence of Med12 somatic mutations, little is known about the role they play in the tumorigenicity of hUFs. Moreover, the role of Med12 in the modulation of human leiomyoma cell growth has not yet been established. The purpose of this study was to evaluate the role of Med12 in the proliferation of hUF cells through the modulation of Wnt/b-catenin signaling, as well as in the regulation of other fibroid growth-associated signaling pathways. Identification of such signaling pathways that are potentially associated with fibroid cell growth in the context of Med12 will eventually help to develop novel potential therapeutic options for the nonsurgical medical treatment of hUFs.
Although studies have connected Med12 somatic mutations with the activation of Wnt/b-catenin signaling (8, 20) , the precise functional contribution of these mutations is rather unknown. It has also not yet been A recent study demonstrated that b-catenin functions through translocation to the nucleus, whereupon it binds to the T-cell factor/lymphocyte enhancer factor family of transcription factors, resulting in the expression of specific target genes (44) . Several b-catenin target genes, including cyclin D1, are involved in cell proliferation, and b-catenin signaling plays an important role in development and neoplasia (44) . Moreover, constitutive activation of b-catenin in uterine mesenchyme leads to the development of leiomyoma-like tumors in female mice (45) .
Cell proliferation assays revealed a lower proliferation rate of Med12-shRNA cells as compared with controlshRNA cells, which indicates a strong link between Med12 in UF cell proliferation. Moreover, Med12 Immunofluorescence analyses were performed using Med12-shRNA and control-shRNA cells cultured on glass coverslips. Cells were fixed, permeabilized, and incubated with polyclonal anti-fibronectin (E) and anti-collagen type 1 (F) antibodies (1:50 dilution each), followed by incubation with carbocyanine 3-conjugated anti-rabbit secondary antibody. Fibronectin and collagen type 1 expression (red) were monitored by fluorescence microscopy. Cell nuclei were stained with 4 0 ,6-diamidino-2-phenylindole (blue). Photos were taken at magnification of 3200. press.endocrine.org/journal/endoknockdown cells showed induced expression of proapoptotic Bad, whereas the levels of antiapoptotic Bcl-xL were lower as compared with control knockdown cells [Supplemental Fig. 1(B) ], which also supports a link between Med12 and leiomyoma cell survival. The cyclin D1 and cyclin-dependent kinases are frequently overexpressed in carcinogenesis (46) . Reduction of cyclin D1 and cyclin-dependent kinases such as Cdk1 and Cdk2 in Med12 knockdown cells [ Fig. 3 (A) and 3(B)] suggests a role for Med12 in UF cell cycle progression. In addition, various mitogen-activated protein kinases, including ERK, are involved in tumor progression (47) . Our findings (Fig. 3) showed the reduction in the activation of both ERK and AKT signaling in the Med12 knockdown cells, evidencing a role for Med12 in fibroid tumor progression. It is well established that the sex steroid receptors are upregulated in hUFs and that they play a role in fibroid growth (38-41). Our results (Fig. 4) show that the levels of ER-a, PR-A, and PR-B were significantly reduced in Med12-shRNA cells when compared with control-shRNA cells, suggesting that Med12 has a role in the regulation of sex steroid receptors in hUF cells. hUFs exhibit increased levels of ECM deposition as compared with matched normal myometrium (48, 49) . Excessive ECM deposition is associated with hUFs. Collagens, a family of proteins, serve as the main components of the ECM. Collagen type 1 and type III comprise approximately 90% of total collagen (50). Figure 5 shows reduced levels of type 1 collagen in Med12-shRNA cells as compared with control-shRNA cells, providing further evidence that disruption of Med12 expression reduces the characteristic fibroid phenotype. Fibronectin, an ECM protein, is associated with matrix components as well as the promotion of cell adhesion and migration, cytodifferentiation, phagocytosis, and cell growth (51) . Consistent with reduced expression of collagen type 1 in Med12 knockdown cells, we also observed reduced levels of fibronectin in Immunofluorescence analyses were performed, as described in illustration. Cells were fixed, permeabilized, and incubated with anti-Smad2 and anti-Smad3 (10 mg/mL, each antibody), followed by incubation with carbocyanine 3-conjugated anti-rabbit secondary antibody. Either Smad2 or Smad3 expression (red) was monitored by a fluorescent microscopy. Cell nuclei were stained with 4 0 ,6-diamidino-2-phenylindole (blue). Photos were taken at magnification of 3200. (E) Nuclear (N) and cytoplasmic (Cy) extracts were prepared from both Med12-shRNA and control-shRNA cells treated without or with TGF-b3 (10 ng/mL) for 4 hours. A total of 15 mg each cytoplasmic and nuclear extracts was analyzed by Western blots using anti-p-Smad2, anti-Smad2, anti-Smad4, and anti-cyclin D1 antibodies. Poly(ADP-ribose) polymerase (nuclear) and RhoGDI (cytoplasmic) Western blots were used as to show the purity of the separation. (F) Med12-shRNA and control-shRNA cells were cultured, serum starved, and treated with or without TGF-b3 (10 ng/mL) for 4 hours. Equal amounts of cell lysates (1 mg) were used for the immunoprecipitation (IP) assay with both anti-Smad2 and anti-Smad3 antibodies (2 mg each) for 2.5 hours at 4°C. A total of 25 mL protein G-Sepharose beads was added and then incubated for another hour. Immune complex was washed 4 times (5 minutes each), and thereafter Western blot analyses were performed using anti-Smad4 antibody (top panel). Cell lysates were verified by Western blots for expression of p-Smad2, Smad2, and Smad4 proteins. b-actin Western blot was used as the loading control (bottom panels).
Med12-shRNA cells as compared with control-shRNA cells (Fig. 5) , further revealing that the disruption of Med12 protein expression reduces the characteristic fibroid phenotype. Reduced levels of fibronectin expression were also confirmed in Med12 knockdown fibroid primary cells [ Fig. 2(E) and (F) ]. Moreover, PAI-1, a TGFb target, is associated with the process of fibrosis (52) . PAI-1 protein levels were significantly reduced in Med12-shRNA cells (Fig. 5) , which also establishes that disruption of Med12 protein expression reduces the characteristic fibroid phenotype.
TGF-b primarily exerts its biological function by activating the downstream Smad signaling pathway (53) . TGF-b signaling has been shown to be activated in hUFs and play roles in fibroid pathogenesis (54) . To determine whether Med12 plays a role in the activation of TGF-b signaling, several experiments were performed using Med12 knockdown cells and scrambled control cells. Our findings (Fig. 6) show that Med12-shRNA cells expressed lower levels of TGF-bRII and phospho-Smad2 as well as a reduction in heterotrimeric Smad complex formation when compared with control-shRNA cells, suggesting an association between Med12 and the TGF-b/Smad signaling pathway.
In summary, we successfully generated stable Med12-shRNA--and control-shRNA-expressing cells using a lentivirus-based RNAi strategy. Med12-shRNA cells showed reduced levels of Wnt4 and b-catenin as compared with control-shRNA cells. Med12-shRNA cells also showed lower levels of proliferation as well as reduced expression of cell cycle-associated Cdk1, Cdk2, and cyclin D1 proteins. Moreover, Med12-shRNA cells expressed reduced protein levels of TGF-bRII and reduction in Smad2 phosphorylation, as well as reduced TGF-b3-induced nuclear translocation of Smad2 and Smad3, and heterotrimeric complex formation among Smad2, Smad3, and Smad4; these results provide strong evidence that Med12 is associated with the TGF-bRII/ Smad signaling pathway. Furthermore, disruption of Med12 (by silencing) showed abrogation of fibrotic processes, including reduced expression of ECM components fibronectin, collagen type 1, and PAI-1, which are known as the hallmarks of the fibroid phenotype.
Together, our findings demonstrate that Med12 plays critical roles in the regulation of UF cell proliferation by modulating fibroid growth-associated signaling pathways, including Wnt/b-catenin, sex steroid receptors, TGF-b/Smad, as well as ECM production.
